GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Earnings per Share (Diluted)

Covalon Technologies (TSXV:COV) Earnings per Share (Diluted) : C$-0.03 (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Earnings per Share (Diluted)?

Covalon Technologies's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was C$0.06. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.03.

Covalon Technologies's EPS (Basic) for the three months ended in Jun. 2024 was C$0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.03.

Covalon Technologies's EPS without NRI for the three months ended in Jun. 2024 was C$0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was C$-0.03.

During the past 3 years, the average EPS without NRIGrowth Rate was 15.70% per year.

During the past 13 years, Covalon Technologies's highest 3-Year average EPS without NRI Growth Rate was 39.90% per year. The lowest was -34.10% per year. And the median was 4.20% per year.


Covalon Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Covalon Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Earnings per Share (Diluted) Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -0.27 0.91 -0.38 -0.18

Covalon Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.12 -0.03 0.06 0.06

Competitive Comparison of Covalon Technologies's Earnings per Share (Diluted)

For the Biotechnology subindustry, Covalon Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's PE Ratio falls into.



Covalon Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Covalon Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (A: Sep. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.461-0)/24.783
=-0.18

Covalon Technologies's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(1.448-0)/24.676
=0.06

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Covalon Technologies  (TSXV:COV) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Covalon Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Amir Boloor Director
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies Headlines

No Headlines